Skip to content

AcouSort AB Sustainability Reports

AcouSort AB develops innovative technology products and solutions for the integrated automated preparation of biological samples using ultrasound waves. The technology enables the purification, concentration, staining, and separation of cells, bacteria, and exosomes for clinical research, cell therapies, and diagnostics.

Sector: Professional & technical services

Country: Sweden

Exchange: Nasdaq Stockholm

LEI: 549300PTSH3X6GMBFS32

FIGI: BBG00FD51K95

2 reports from 2024 to 2025